CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59
(Q77220551)
scientific article published on 01 December 2001
scientific article published on 01 December 2001
Language:
Current Data About
CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59
other details
| description | scientific article published on 01 December 2001 |
External Links
| (P356) |
10.1182/BLOOD.V98.12.3383
|
| (P698) |
11719378
|